Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Clinical Link between Human Intestinal Microbiota and Systemic Cancer Therapy
Romy Aarnoutse, Janine Ziemons, John Penders, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 17, pp. 4145-4145
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Fecal Microbiota Transplantation Prevents Intestinal Injury, Upregulation of Toll-Like Receptors, and 5-Fluorouracil/Oxaliplatin-Induced Toxicity in Colorectal Cancer
Ching-Wei Chang, Hung-Chang Lee, Li-Hui Li, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 2, pp. 386-386
Open Access | Times Cited: 168
Modulatory effects of polysaccharides from plants, marine algae and edible mushrooms on gut microbiota and related health benefits: A review
Henan Zhang, Fuchun Jiang, Jinsong Zhang, et al.
International Journal of Biological Macromolecules (2022) Vol. 204, pp. 169-192
Closed Access | Times Cited: 82
Gut microbiota and short‐chain fatty acid alterations in cachectic cancer patients
Jorne Ubachs, Janine Ziemons, Zita Soons, et al.
Journal of Cachexia Sarcopenia and Muscle (2021) Vol. 12, Iss. 6, pp. 2007-2021
Open Access | Times Cited: 101
Microbiota from alginate oligosaccharide-dosed mice successfully mitigated small intestinal mucositis
Pengfei Zhang, Jing Liu, Bohui Xiong, et al.
Microbiome (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 79
Diet, Microbiome, and Cancer Immunotherapy—A Comprehensive Review
Michał Szczyrek, Paulina Bitkowska, Patryk Chunowski, et al.
Nutrients (2021) Vol. 13, Iss. 7, pp. 2217-2217
Open Access | Times Cited: 74
Inflammation and cancer: friend or foe?
Andrés David Turizo-Smith, Samantha Córdoba-Hernandez, Lidy Vannessa Mejía-Guarnizo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 12
Microbiota and Obesity: Where Are We Now?
Andrea Ballini, Salvatore Scacco, Mariarosaria Boccellino, et al.
Biology (2020) Vol. 9, Iss. 12, pp. 415-415
Open Access | Times Cited: 63
The Gut Microbiome and Cancer Immunotherapy: Can We Use the Gut Microbiome as a Predictive Biomarker for Clinical Response in Cancer Immunotherapy?
Byeongsang Oh, Frances Boyle, Nick Pavlakis, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 4824-4824
Open Access | Times Cited: 47
Exploring the Modulatory Effects of Gut Microbiota in Anti-Cancer Therapy
Wenyu Li, Xiaorong Deng, Tingtao Chen
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 45
Gut Microbiota: Influence on Carcinogenesis and Modulation Strategies by Drug Delivery Systems to Improve Cancer Therapy
Runqi Zhu, Tianqun Lang, Wenlu Yan, et al.
Advanced Science (2021) Vol. 8, Iss. 10
Open Access | Times Cited: 43
Gut Metabolites and Breast Cancer: The Continuum of Dysbiosis, Breast Cancer Risk, and Potential Breast Cancer Therapy
Kayla Jaye, Dennis Chang, Chun Guang Li, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9490-9490
Open Access | Times Cited: 33
Fusobacterium nucleatum: a novel immune modulator in breast cancer?
Alexa Little, Mark Tangney, Michael M. Tunney, et al.
Expert Reviews in Molecular Medicine (2023) Vol. 25
Open Access | Times Cited: 18
Relationship Between the Gut Microbiome and Systemic Chemotherapy
Samantha M. Ervin, Siddharth Venkat Ramanan, Aadra P. Bhatt
Digestive Diseases and Sciences (2020) Vol. 65, Iss. 3, pp. 874-884
Open Access | Times Cited: 48
Emerging Evidence of the Gut Microbiome in Chemotherapy: A Clinical Review
Byeongsang Oh, Frances Boyle, Nick Pavlakis, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 38
Gut Microbiota Dynamics during Chemotherapy in Epithelial Ovarian Cancer Patients Are Related to Therapeutic Outcome
Federica D’Amico, Anna Myriam Perrone, Simone Rampelli, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 3999-3999
Open Access | Times Cited: 37
Changes in intestinal microbiota in postmenopausal oestrogen receptor-positive breast cancer patients treated with (neo)adjuvant chemotherapy
Romy Aarnoutse, Janine Ziemons, Lars E. Hillege, et al.
npj Breast Cancer (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 28
Gut Microbiota Profiling in Patients With HER2-Negative Metastatic Breast Cancer Receiving Metronomic Chemotherapy of Capecitabine Compared to Those Under Conventional Dosage
Xiuwen Guan, Fei Ma, Xiaoying Sun, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 39
Gut microbiota and metabolic aspects of cancer cachexia
Janine Ziemons, Marjolein L. Smidt, Steven W.M. Olde Damink, et al.
Best Practice & Research Clinical Endocrinology & Metabolism (2021) Vol. 35, Iss. 3, pp. 101508-101508
Open Access | Times Cited: 30
The Interplay between Microbiota and Chemotherapy-Derived Metabolites in Breast Cancer
Julio Plaza‐Díaz, Ana I. Álvarez‐Mercado
Metabolites (2023) Vol. 13, Iss. 6, pp. 703-703
Open Access | Times Cited: 11
The efficacy and safety of qiwei baizhu san in the treatment of type 2 diabetes mellitus: a systematic review and meta-analysis
Quan Zhang, Hongyan Liu, Jiahong Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
The gut microbiota during tamoxifen therapy in patients with breast cancer
Lars E. Hillege, David Barnett, Janine Ziemons, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Insights into the gut microbiome-metabolite dynamics in breast cancer
Haseeb Manzoor, Masood ur Rehman Kayani
Gut Microbes Reports (2025) Vol. 2, Iss. 1, pp. 1-23
Open Access
Role of gut-lung microbiome crosstalk in COVID-19
B. S. Srinath, Rajesh P. Shastry, Sukesh Kumar Bajire
Research on Biomedical Engineering (2020) Vol. 38, Iss. 1, pp. 181-191
Open Access | Times Cited: 28
Fecal Metabolic Profiling of Breast Cancer Patients during Neoadjuvant Chemotherapy Reveals Potential Biomarkers
O. Zidi, Nessrine Souai, Henda Raies, et al.
Molecules (2021) Vol. 26, Iss. 8, pp. 2266-2266
Open Access | Times Cited: 27
The intestinal microbiome, weight, and metabolic changes in women treated by adjuvant chemotherapy for breast and gynecological malignancies
Atara Uzan-Yulzari, Maya Morr, Hala Tareef-Nabwani, et al.
BMC Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top